Results 141 to 150 of about 34,166 (308)

DIABETIC NEPHROPATHY [PDF]

The Journal of Clinical Endocrinology & Metabolism, 1955
openaire   +2 more sources

Monitoring Progression of Diabetic Nephropathy

, 1985
Hans‐Henrik Parving, Allan R. Andersen, U. Smidt   +2 more
openalex   +2 more sources

Dietary management of patients with diabetic nephropathy [PDF]

, 1993
Catherine A. Hadfield
openalex   +1 more source

European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach

United European Gastroenterology Journal, EarlyView.
Infographic. This infographic summarizes the diagnostic approach to CeD in adults, including initial serological testing, histological confirmation, criteria for a no‐biopsy diagnosis, seronegative CeD, potential CeD, and the role of gluten challenge. Source: Authors' own creation (based on current clinical guidelines).
Abdulbaqi Al‐Toma, Fabiana Zingone, Federica Branchi, Annalisa Schiepatti, Georgia Malamut, Cristina Canova, Isabella Rosato, Honoria Ocagli, Nick Trott, Luca Elli, Alina Popp, Carmen Gianfrani, Renata Auricchio, Andra Neefjes‐Borst, David S. Sanders, Christophe Cellier, Chris J. Mulder, Gerd Bouma, Knut E. A. Lundin, Ludvig M. Sollid, Michael Schumann   +20 more
wiley   +1 more source

Creatinine metabolism in diabetic nephropathy

, 1989
Yoshiharu Tsubakihara, Takahito Itoh, Eisaku Kitamura, Noriyuki Okada, Isao Nakanishi, Nobutoshi Iida, Masaki Togawa   +6 more
openalex   +2 more sources

Extracellular vesicles derived from silicate‐stimulated antler reserve mesenchymal cells alleviate kidney damage in diabetic nephropathy through inhibiting abnormal angiogenesis and apoptosis

VIEW, EarlyView.
A novel bioengineering platform was invented to harness simple silicate ions to command highly regenerative deer antler cells, transforming them into super‐factories that massively produce customized extracellular vesicles (Si‐RM‐EVs) rich in therapeutic miR‐148a‐3p, dwarfing natural EV output and payload.
Pengfei Hu, Zhaowenbin Zhang, Dongxu Wang, Xiuying Li, Jiping Li, Jinchi Ying, Tiantian Jiang, Chen Zhao, Jiang Chang, Chunyi Li   +9 more
wiley   +1 more source

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy [PDF]

, 1995
K. S. L. Lam, Ikp Cheng, Edward Janus, Richard Pang   +3 more
openalex   +1 more source

Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective No large‐scale studies exist investigating glycaemic control around conception and preeclampsia risk. Design Population‐based nationwide cohort study using the National Diabetes Register and other health registers. Setting Sweden. Population Singleton pregnancies between 2003 and 2019 (N = 1 689 301); 4429 with type 1 diabetes (T1DM)
Natalie Holowko, Nathalie Roos, Björn Pasternak, Jonas Söderling, Martin Neovius, Soffia Gudbjörnsdottir, Anna Sandström, Jonas F. Ludvigsson, Olof Stephansson   +8 more
wiley   +1 more source

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

, 1991
Goji Hasegawa, Koji Nakano, Manabu Sawada, Kazuko Uno, Yoji Shibayama, Kazuharu Ienaga, Motoharu Kondo   +6 more
openalex   +1 more source

Abnormal regulation of cell membrane fluidity in diabetic nephropathy [PDF]

, 1998
S. C. Jones, T.H. Thomas, Sally M. Marshall   +2 more
openalex   +1 more source